Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 January 2025 | Story Anthony Mthembu | Photo Supplied
Prof Solomon Werta
Prof Solomon Werta, UFS alumnus and Vice-President: Administration and Development at Dire Dawa University, continues to inspire as one of Ethiopia's youngest leaders in higher education.

Throughout the progression of his career, the UFS alumnus, Prof Solomon Werta – Vice-President: Administration and Development at the Dire Dawa University (DDU) – has been the ‘youngest’ to occupy positions of leadership in several instances. 

In fact, the DDU appointed Prof Werta as Vice-President: Research and Community Service in 2020, making him the youngest vice-president of any public university in Ethiopia. According to Prof Werta, when it comes to senior management roles in universities and government, the norm is that the positions are held by middle-aged, mature leaders. However, after a unanimous vote by senate members at the university, he assumed that role at the age of 31. “Holding such a senior position at that age makes me a role model not only for a generation of young people, but for those at the University of the Free State who may be following my career,” Prof Werta stated. 

What the role entailed 

As Vice-President: Research and Community Service, he was responsible for driving research, innovation, technology transfer, community engagement, and growth within the institution and the community at large. As such, some of his highlights within this role include establishing a university community radio station to serve both the university and the Dire Dawa community, establishing new university journals such as the Harla journal, and establishing a nationally accredited institutional review board, among others. 

He occupied this role until November 2023 when he was promoted to his current role as Vice-President: Administration and Development at the DDU. Prof Werta credits this most recent promotion to the dedication and hard work he put into his previous role, as well as the knowledge and experience he acquired during his time at the UFS. 

In recognition of his work as a researcher within the Department of Physics at the DDU, Prof Werta was also promoted to Associate Professor in Physics. As a result, he indicates that he can be regarded as the youngest associate professor of physics in Ethiopia. Therefore, he continues to contribute to his institution and beyond on these accounts. 

What the future holds 

Prof Werta indicated that he plans on continuing to make strides as his career progresses, particularly in his role as Vice-President: Administration and Development. “I’d like to focus on increasing the university’s internal revenue, particularly through urban farming and other businesses using our academics,” said Prof Werta. In addition, he would also like to work on changing the university’s internal business practices, particularly the automation and digitalisation of the university system and the implementation of a contemporary university property management system, among others. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept